| Genetic characterization of a unique neuroendocrine transdifferentiation prostate circulating tumor cell-derived eXplant model |
Karim Fizazi, Yohann Loriot, Emma Pailler, ... |
01/12/2020 |
Nature Communications |
| Calreticulin del52 and ins5 knock-in mice recapitulate different myeloproliferative phenotypes observed in patients with MPN |
Patrick Gonin, Laure Touchard |
01/12/2020 |
Nature Communications |
| Exploitation of the chick embryo chorioallantoic membrane (CAM) as a platform for anti-metastatic drug testing |
Ludovic Lacroix, Vincent Faugeroux, Marianne Oulhen, ... |
01/12/2020 |
Scientific Reports |
| Budget impact analysis of fixed dose versus weight-based dosing regimen of nivolumab and pembrolizumab in the treatment of non-small cell lung cancer |
Boris Duchemann |
01/12/2020 |
Vaccines |
| Integrating circulating biomarkers in the immune checkpoint inhibitor treatment in lung cancer |
Nathalie Chaput, Lisa Boselli, Lydie Cassard, ... |
01/12/2020 |
Cancers |
| Impact of intercurrent introduction of steroids on clinical outcomes in advanced non-small-cell lung cancer (Nsclc) patients under immune-checkpoint inhibitors (ici) |
Nathalie Chaput |
01/10/2020 |
Cancers |
| XPO1 regulates erythroid differentiation and is a new target for the treatment of β-thalassemia |
Patrick Gonin, Marc Gastou |
01/09/2020 |
Haematologica |
| DNA FISH diagnostic assay on cytological samples of thyroid follicular neoplasms |
Voichita Suciu, Guillaume Meurice, Abir Al Ghuzlan, ... |
01/09/2020 |
Cancers |
| Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers |
Zahra Kadri |
06/08/2020 |
Blood |
| An Accessible and Unique Insight into Metastasis Mutational Content Through Whole-exome Sequencing of Circulating Tumor Cells in Metastatic Prostate Cancer |
Emma Pailler, Vincent Faugeroux, Marianne Oulhen, ... |
01/08/2020 |
European urology oncology |
| Pickering emulsions with ethiodized oil and nanoparticles for slow release of intratumoral anti-CTLA4 immune checkpoint antibodies |
Karine Ser-Le Roux, Mélanie Polrot |
21/06/2020 |
Journal for immunotherapy of cancer |
| Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond SMARCA4 Mutations: A Comprehensive Genomic Analysis |
Marc Deloger |
19/06/2020 |
Cells |
| Molecular mechanisms of resistance to BRAF and MEK inhibitors in BRAF<sup>V600E</sup> non–small cell lung cancer |
Jean Yves Scoazec |
01/06/2020 |
European Journal of Cancer |
| Burkitt and Burkitt-Like Lymphomas: a Systematic Review |
Valérie Camara-Clayette |
01/04/2020 |
Current Oncology Reports |
| Antidrug antibodies against immune checkpoint blockers: Impairment of drug efficacy or indication of immune activation? |
Nathalie Chaput |
15/02/2020 |
Clinical Cancer Research |
| Spontaneous molecular response of IDH2 acute myeloid leukemia |
Valérie Camara-Clayette |
01/02/2020 |
Annals of Hematology |
| Multilayer intraclonal heterogeneity in chronic myelomonocytic leukemia |
Philippe Rameau, Larissa Lordier, Thibault Dayris |
01/01/2020 |
Haematologica |
| Diverse resistance mechanisms to the third-generation ALK inhibitor lorlatinib in ALK-rearranged lung cancer |
Ludovic Lacroix, Jean Yves Scoazec, Catherine Richon |
01/01/2020 |
Clinical Cancer Research |
| Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancer |
Nathalie Droin, Ludovic Lacroix, Cécile Jovelet, ... |
01/03/2020 |
Annals of Oncology |
